More than 2,000 Biopharma Leaders Come Together at Veeva R&D and Quality Summit to Advance Drug Development
Keynote speakers AbbVie, AstraZeneca, Boehringer Ingelheim, CSL Behring, and GSK headline one of the industry's largest events for driving collaboration and innovation
PLEASANTON, Calif., Sept. 13, 2022 /PRNewswire/ -- Veeva Systems, Inc. (NYSE: VEEV) today announced that visionaries from AbbVie, AstraZeneca, Boehringer Ingelheim, CSL Behring, and GSK will be keynote speakers at the 2022 Veeva R&D and Quality Summit on Oct.19 and 20 in Boston. Speakers will showcase how innovations and advancements in clinical, quality, regulatory, and safety enable greater efficiency and speed across the product lifecycle.
With more than 2,000 industry professionals and over 100 sessions, Veeva R&D and Quality Summit is one of life sciences' largest and most impactful events. Attendees will learn strategies to establish a clinical data foundation for patient-centric digital trials, transform quality management across the value chain, optimize regulatory operations, and deliver new levels of productivity in safety. Featured keynotes and sessions include:
"Life sciences has made significant progress in streamlining processes and making information sharing easier," said Jim Reilly, vice president, Veeva Development Cloud strategy. "Veeva R&D and Quality Summit will bring the industry back together in person to connect with peers, share learnings, and discuss strategies that can move the industry forward."
The event is open exclusively to life sciences industry professionals. Register and stay up to date on the agenda and program details at veeva.com/Summit.
About Veeva Systems
Veeva is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,000 customers, ranging from the world's largest pharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/more-than-2-000-biopharma-leaders-come-together-at-veeva-rd-and-quality-summit-to-advance-drug-development-301622723.html
SOURCE Veeva Systems
Company Codes: NYSE:VEEV